Product
SHR-1905
3 clinical trials
2 indications
Indication
AsthmaIndication
Chronic RhinosinusitisClinical trial
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study to Evaluate the Efficacy and Safety of SHR-1905 in Subjects With Severe Uncontrolled Asthma.Status: , Estimated PCD: 2024-10-31
Clinical trial
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal PolypsStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Single Subcutaneous Administered SHR-1905 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-11-12